Efficacy and safety of MCNA in patients with nonmuscle invasive bladder cancer at high risk for recurrence and progression after failed treatment with bacillus Calmette-Guérin Academic Article uri icon

Overview

MeSH Major

  • Mycobacterium phlei
  • Nucleic Acids
  • Urinary Bladder Neoplasms

abstract

  • Intravesical MCNA achieved significant activity in patients at high risk with nonmuscle invasive bladder cancer in whom bacillus Calmette-Guérin treatment failed, especially those with papillary only tumors and those with bacillus Calmette-Guérin relapse. A durable response was seen, particularly in patients with a response at 1 year. MCNA offers an option for patients who are not candidates for or who refuse cystectomy.

publication date

  • January 2015

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2014.09.109

PubMed ID

  • 25286009

Additional Document Info

start page

  • 1135

end page

  • 43

volume

  • 193

number

  • 4